• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主要结局指标及其在临床试验中的重要性。

The primary outcome measure and its importance in clinical trials.

作者信息

Andrade Chittaranjan

机构信息

Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore, India

出版信息

J Clin Psychiatry. 2015 Oct;76(10):e1320-3. doi: 10.4088/JCP.15f10377.

DOI:10.4088/JCP.15f10377
PMID:26528658
Abstract

The primary outcome measure is the outcome that an investigator considers to be the most important among the many outcomes that are to be examined in the study. The primary outcome needs to be defined at the time the study is designed. There are 2 reasons for this: it reduces the risk of false-positive errors resulting from the statistical testing of many outcomes, and it reduces the risk of a false-negative error by providing the basis for the estimation of the sample size necessary for an adequately powered study. This article discusses the setting of the primary outcome measure, the need for it, the increased risk of false-positive and false-negative errors in secondary outcome results, how to regard articles that do not state the primary outcome, how to interpret results when secondary outcomes are statistically significant but not the primary outcome, and limitations of the concept of a primary outcome measure in clinical trial research.

摘要

主要结局指标是研究者在研究中要考察的众多结局里认为最重要的那个结局。主要结局需要在研究设计时就加以定义。这样做有两个原因:它降低了对众多结局进行统计检验导致假阳性错误的风险,并且通过为估算有足够检验效能的研究所必需的样本量提供依据,降低了假阴性错误的风险。本文讨论了主要结局指标的设定、其必要性、次要结局结果中假阳性和假阴性错误风险的增加、如何看待未陈述主要结局的文章、当次要结局具有统计学显著性但主要结局不具有统计学显著性时如何解读结果,以及临床试验研究中主要结局指标概念的局限性。

相似文献

1
The primary outcome measure and its importance in clinical trials.主要结局指标及其在临床试验中的重要性。
J Clin Psychiatry. 2015 Oct;76(10):e1320-3. doi: 10.4088/JCP.15f10377.
2
Randomized controlled trials and psychotherapy research.随机对照试验与心理治疗研究。
Am J Psychiatry. 2007 Jan;164(1):7-8. doi: 10.1176/ajp.2007.164.1.7.
3
Traditional and alternative research designs and methods in clinical pediatric psychopharmacology.临床儿科精神药理学中的传统及替代研究设计与方法
J Am Acad Child Adolesc Psychiatry. 1996 Oct;35(10):1292-303. doi: 10.1097/00004583-199610000-00016.
4
Trussed in evidence? Ambiguities at the interface between clinical evidence and clinical practice.证据确凿?临床证据与临床实践之间接口处的模糊性。
Transcult Psychiatry. 2009 Mar;46(1):16-37. doi: 10.1177/1363461509102285.
5
Stepped care: doing more with less?阶梯式照护:用更少的资源做更多的事?
J Consult Clin Psychol. 2000 Aug;68(4):580-5.
6
Psychopharmacology: the need for effectiveness trials to inform evidence-based psychiatric practice.精神药理学:开展有效性试验以指导循证精神病学实践的必要性。
Psychiatr Serv. 2005 Jun;56(6):649-51. doi: 10.1176/appi.ps.56.6.649.
7
Traumatized refugees: morbidity, treatment and predictors of outcome.受创伤的难民:发病率、治疗及预后预测因素
Dan Med J. 2014 Aug;61(8):B4871.
8
The 2 "Es" of research: efficacy and effectiveness trials.
Can J Psychiatry. 2002 Aug;47(6):552-6. doi: 10.1177/070674370204700607.
9
Behavioral effects of current Alzheimer's disease treatments: a descriptive review.当前阿尔茨海默病治疗方法的行为学效应:描述性综述。
Alzheimers Dement. 2008 Jan;4(1):49-60. doi: 10.1016/j.jalz.2007.10.011.
10
Psychotropic drugs and paediatrics: a critical need for more clinical trials.精神药物与儿科:更需临床试验。
J Med Ethics. 2012 Apr;38(4):250-2. doi: 10.1136/medethics-2011-100003. Epub 2011 Nov 2.

引用本文的文献

1
Relative sensitivity and preference of indicators in pharmaceutical trials of psoriasis and psoriatic arthritis.银屑病和银屑病关节炎药物试验中指标的相对敏感性和偏好性
Eur J Med Res. 2025 Aug 26;30(1):803. doi: 10.1186/s40001-025-02995-5.
2
Association between age-related hearing loss and depression: A systematic review and meta-analysis.年龄相关性听力损失与抑郁症之间的关联:一项系统评价和荟萃分析。
PLoS One. 2025 Jan 3;20(1):e0298495. doi: 10.1371/journal.pone.0298495. eCollection 2025.
3
Discrepancies between pre-specified and reported primary outcomes: A cross-sectional analysis of randomized controlled trials in gastroenterology and hepatology journals.
预先指定和报告的主要结局之间的差异:胃肠病学和肝脏病学杂志随机对照试验的横断面分析。
PLoS One. 2024 Nov 22;19(11):e0305027. doi: 10.1371/journal.pone.0305027. eCollection 2024.
4
Analysis of the Current Status of Outcome Indicators of Randomised Controlled Trials of Traditional Chinese Medicine for the Treatment of Qi and Yin Deficiency in Coronary Heart Disease.冠心病气阴两虚证中医药随机对照试验结局指标现状分析
Int J Gen Med. 2024 Aug 16;17:3575-3590. doi: 10.2147/IJGM.S473899. eCollection 2024.
5
Primary outcomes, secondary outcomes, and their relevance to how many papers are published from a study: A primer for authors, reviewers, and editors.主要结局、次要结局及其与一项研究发表论文数量的相关性:给作者、审稿人和编辑的入门指南
Indian J Psychiatry. 2024 May;66(5):472-476. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_404_24. Epub 2024 May 20.
6
Mendelian randomization as a tool to inform drug development using human genetics.孟德尔随机化作为一种利用人类遗传学为药物研发提供信息的工具。
Camb Prism Precis Med. 2023 Feb 8;1:e16. doi: 10.1017/pcm.2023.5. eCollection 2023.
7
Types of Analysis: Planned (prespecified) vs Post Hoc, Primary vs Secondary, Hypothesis-driven vs Exploratory, Subgroup and Sensitivity, and Others.分析类型:计划(预先指定)分析与事后分析、主要分析与次要分析、假设驱动分析与探索性分析、亚组分析和敏感性分析以及其他分析。
Indian J Psychol Med. 2023 Nov;45(6):640-641. doi: 10.1177/02537176231216842. Epub 2023 Nov 22.
8
The impact of measurement on clinical trials: Comparison of preliminary outcomes of a brief mobile intervention for autistic adults using multiple measurement approaches.测量对临床试验的影响:使用多种测量方法对自闭症成人进行简短移动干预的初步结果比较。
Autism Res. 2024 Feb;17(2):432-442. doi: 10.1002/aur.3095. Epub 2024 Feb 6.
9
Selection of indicators reporting response rate in pharmaceutical trials for systemic lupus erythematosus: preference and relative sensitivity.系统性红斑狼疮药物临床试验报告缓解率的指标选择:偏好和相对敏感性。
Lupus Sci Med. 2023 Oct;10(2). doi: 10.1136/lupus-2023-000942.
10
Completeness and consistency of primary outcome reporting in COVID-19 publications in the early pandemic phase: a descriptive study.新冠疫情早期阶段 COVID-19 研究出版物中主要结局报告的完整性和一致性:描述性研究。
BMC Med Res Methodol. 2023 Jul 29;23(1):173. doi: 10.1186/s12874-023-01991-9.